Megan joined SV in 2020 and is a Vice President for the MedTech Convergence Fund (MCF), primarily focusing on medtech and digital health investments.
Prior to joining SV, Megan was a Senior Life Sciences Consultant at Charles River Associates in their New York office, where she led strategic projects for top biopharma and medtech clients across a wide range of therapeutic areas.
Before CRA, Megan spent six years at Novate Medical (acquired by BTG) in Galway, Ireland developing novel vascular devices from design to FDA approval. During business school, Megan did an internship with The Foundry and Lightstone Ventures in Menlo Park, where she evaluated device and drug/device combination products.
Outside of SV, Megan is a member of the HBS Healthcare Alumni Association and the New England Venture Network.
Academic Credentials
BE, Biomedical Engineering, National University of Ireland, Galway; MBA, Harvard Business School
